The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis
Journal of Clinical EpidemiologyPublished 1 February 2002
Debra Lerner, John I. Reed, Elena Massarotti, Lisa M. Wester, Thomas Burke
Citations227
SJR quartileQ1
SJR score3.15
SNIP2.66
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The WLQ is an accurate and reliable source of information for assessing the work impact of OA and correlated significantly with arthritis pain, stiffness, and functional limitation, and self-reported work productivity.
Abstract
The 25-item Work Limitations Questionnaire (WLQ) was recently developed to measure health-related decrements in ability to perform job roles among employed individuals. Research has demonstrated its validity and reliability in several populations. We assessed the WLQ's performance when administered to patients with osteoarthritis (OA), which is a leading cause of work disability and productivity loss. We recruited a representative sample of 230 employed, confirmed OA patients and a comparison group of 37 healthy employed controls. Subjects completed a mail survey. In tests of the WLQ's scale internal reliability, the questionnaire met all established criteria. Additionally, in construct validity tests, the WLQ correctly detected OA vs. control group differences, and correlated significantly with arthritis pain, stiffness, and functional limitation, and self-reported work productivity. The WLQ is an accurate and reliable source of information for assessing the work impact of OA.
Keywords
MedicineHealth Professions
Annals of the Rheumatic DiseasesRadiological Assessment of Osteo-Arthrosis
12,445 Citations1957Jan Kellgren, J. S. Lawrence
It was concluded that, to ensure maximum uniformity in grading x rays in field surveys and therapeutic trials, all readings should be made by the same observer, preferably at a single session.
Health Measurement Scales: A Practical Guide to Their Development and Use
9,651 Citations1989David L. Streiner, Geoffrey R. Norman +1 more
This chapter discusses the design of items, their properties, and methods of administration, and some of the considerations that went into designing the items.
Choice Reviews OnlineHealthy work: stress, productivity, and the reconstruction of working life
8,294 Citations1990
Medical CareThe Sickness Impact Profile: Development and Final Revision of a Health Status Measure
4,655 Citations1981Marilyn Bergner, Ruth A. Bobbitt +2 more
The final development of the Sickness Impact Profile (SIP), a behaviorally based measure of health status, is presented and a technique for describing and assessing similarities and differences among groups was developed using profile and pattern analysis.
Arthritis & RheumatismEstimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
2,660 Citations1998Reva C. Lawrence, Charles G. Helmick +12 more
Given the limitations of the data on which they are based, this report provides the best available prevalence estimates for arthritis and other rheumatic conditions overall, and for selected musculoskeletal disorders, in the US population.
Health Measurement Scales
2,570 Citations2014David L. Streiner, Geoffrey R. Norman +1 more
Medical CarePerformance of a Five-Item Mental Health Screening Test
1,620 Citations1991Donald M. Berwick, Jane M. Murphy +4 more
TheMHI-5 was as good as the MHI-18 and the GHQ-30, and better than the SSI-28, for detecting most significant DIS disorders, including major depression, affective disorders generally, and anxiety disorders.
Medical CareThe Work Limitations Questionnaire
944 Citations2001Debra Lerner, Benjamin C. Amick +4 more
With 25 items, 4 dimensions (limitations handling time, physical, mental-interpersonal, and output demands), and a 2-week reporting period, the Work Limitations Questionnaire demonstrated high reliability and validity.
Choice Reviews OnlineDisability in America: toward a national agenda for prevention
899 Citations1992
This comprehensive agenda addresses the need for improved methods for collecting disability data, specific research questions, directions for university training, reform in insurance coverage, prenatal care, vocational training, and a host of other arenas for action.
Arthritis & RheumatismAIMS2. The Content and Properties of a Revised and Expanded Arthritis Impact Measurement Scales Health Status Questionnaire
895 Citations1992Robert F. Meenan, John H. Mason +3 more
The AIMS2 is a revised and expanded health status questionnaire with excellent measurement properties that should be useful in arthritis clinical trials and in outcomes research.
PubMedRecommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.
745 Citations1997Nicholas Bellamy, John Kirwan +8 more
A consensus was reached by at least 90% of participants that the following 4 domains should be evaluated in future phase III trials of knee, hip, and hand OA: pain, physical function, patient global assessment, and, for studies of one year or longer, joint imaging.
Scandinavian Journal of RheumatologyWOMAC Osteoarthritis Index: Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis
478 Citations1999Ewa M. Roos
The Swedish version of WOMAC is a reliable, valid, and responsive instrument with metric properties in agreement with the original widely used version.
PharmacoEconomicsHealthcare Resource and Lost Labour Costs of Migraine Headache in the US
352 Citations1992Jane T. Osterhaus, Donna Gutterman +1 more
Migraine headache is responsible for significantly more healthcare resource and lost labour costs than previously reported and the extrapolated costs to employers ranged from $US5.6 billion to $US17.2 billion dollars annually due to decreased productivity and missed work days.
Mayo Clinic ProceedingsTreatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial
350 Citations1999W. Bensen, Justus J. Fiechtner +8 more
COX-2 inhibition with celecoxib is an effective approach for the treatment of osteoarthritis, as seen by clinical improvement in signs and symptoms comparable to treatment with naproxen.
ThoraxAssessment of Quality of Life in Clinical Trials of Cardiovascular Therapies
344 Citations1985DMG
Primary pulmonary malignant lymphoma: clinical and pathological findings, immunocytochemical and ultrastructural studies, and a comparison with other localized lymphomas.
PubMedReliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar disc degeneration.
278 Citations1993N.E. Lane, Michael C. Nevitt +2 more
Arthritis & RheumatismAn assessment of the annual and long-term direct costs of rheumatoid arthritis: The impact of poor function and functional decline
238 Citations1999Ed Yelin, Lee A. Wanke
The distribution of direct medical care costs of rheumatoid arthritis over 1-year and 11-year periods are described and the impact of poor function and functional decline on direct costs is evaluated.
SpineA Review of Health-Related Work Outcome Measures and Their Uses, and Recommended Measures
219 Citations2000Benjamin C. Amick, Debra Lerner +3 more
A window into health-related work outcomes research is created by considering the reasons for measuring these outcomes and briefly reviewing and illustrating several classes of measures, and a new work-related health outcome tool for measuring successful return to work (RTW) is discussed.
PubMedIndirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
192 Citations1997S. E. Gabriel, C. S. Crowson +2 more
Disease specific indirect and nonmedical costs for OA are substantial and approach those for RA, which has important societal implications, given the high prevalence of OA.
Arthritis & RheumatismSocial and economic impacts of four musculoskeletal conditions
140 Citations1983Jane S. Kramer, Edward H. Yelin +1 more
It is found that as a broad group, persons with musculoskeletal disease experience about the same amount of restriction in activity and use about theSame amount of medical care as U.S. citizens as a whole.
The NORC General Social Survey: A User's Guide
137 Citations1992James Brandon Davis, Tom Smith
Journal of Clinical EpidemiologySubstantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: Comparisons with rheumatoid arthritis
118 Citations1989Theodore Pincus, Jean M. Mitchell +1 more
The results suggest that greater attention to demographic and comorbidity variables may be indicated in efforts to control economic losses associated with arthritis.
Disability and RehabilitationA national survey of health-related work limitations among employed persons in the United States
117 Citations2000Debra Lerner, Benjamin C. Amick +2 more
This study contributes new information concerning the implications of chronic health problems for working people and the significant risks for workers with multiple chronic conditions.
Arthritis & RheumatismSelf-reported functional status in osteoarthritis of the knee in a rural southern community: The role of sociodemographic factors, obesity, and knee pain
105 Citations1996Joanne M. Jordan, George Luta +5 more
Knee pain severity was more important than radiographic knee OA severity in determining disability, and obesity was independently associated with disability and compounded disability from knee pain.
Clinical TherapeuticsComparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee
27 Citations1995A. Weaver, Bernard Rubin +12 more
The study showed that oxaprozin 1200 mg once daily was statistically significantly more efficacious than nabumetone 1000mg once daily for the treatment of patients with moderate-to-severe OA of the knee.
Clinical TherapeuticsThe efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee
15 Citations1996William S. Makarowski
A 1500-mg/d dose of nabumetone is required for efficacy equivalent to that of the recommended starting dose of oxaprozin, 1200 mg/d, in relieving the symptoms of OA, combined with the results of an earlier study showed.